Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report

J Assist Reprod Genet. 2001 Jan;18(1):30-3. doi: 10.1023/a:1026498629324.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Estradiol / blood
  • Female
  • Fertility Agents, Female / administration & dosage
  • Fertility Agents, Female / therapeutic use*
  • Follicle Stimulating Hormone / blood
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Gonadotropin-Releasing Hormone / agonists*
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors
  • Gonadotropin-Releasing Hormone / therapeutic use*
  • Hormone Antagonists / administration & dosage
  • Hormone Antagonists / therapeutic use*
  • Humans
  • Leuprolide / administration & dosage
  • Leuprolide / therapeutic use*
  • Luteinizing Hormone / blood
  • Luteinizing Hormone / metabolism
  • Luteinizing Hormone / physiology*
  • Male
  • Oocytes / drug effects*
  • Oocytes / physiology
  • Pregnancy
  • Pregnancy Outcome
  • Progesterone / blood
  • Sperm Injections, Intracytoplasmic / methods

Substances

  • Fertility Agents, Female
  • Hormone Antagonists
  • Gonadotropin-Releasing Hormone
  • Progesterone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Leuprolide
  • ganirelix